Advanced Pancreatic Adenocarcinoma clinical trials

Explore recruiting advanced pancreatic adenocarcinoma clinical trials.

Recruiting advanced pancreatic adenocarcinoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Pancreatic Adenocarcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Sotorasib combined with first-line chemotherapy for advanced pancreatic adenocarcinoma with KRAS p.G12C mutation

France, Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Phase 2, Randomized, Open-Label, Controlled Study to Evaluate the Efficacy and Safety of Ampligen® Compared to Control Group / No Treatment Following FOLFIRINOX in Subjects with Locally Advanced Pancreatic Adenocarcinoma

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

RR001 in Combination with Chemotherapy for Patients with Locally Advanced Pancreatic Adenocarcinoma: Open-label, Non-randomized Dose Escalation Phase I/IIa Study

Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A Phase II/III Randomized, Open-Label Clinical Study of Napabucasin in Combination with Weekly Paclitaxel and Low-dose Gemcitabine in Patients with Metastatic Pancreatic Cancer Following Chemotherapy Failure

France, Spain

Phase II and Phase III (Integrated) EU CTIS Study details

Advanced Pancreatic Adenocarcinoma trials by city

Advanced Pancreatic Adenocarcinoma in Toronto Advanced Pancreatic Adenocarcinoma in Vancouver Advanced Pancreatic Adenocarcinoma in Montreal Advanced Pancreatic Adenocarcinoma in Calgary Advanced Pancreatic Adenocarcinoma in Edmonton Advanced Pancreatic Adenocarcinoma in Ottawa Advanced Pancreatic Adenocarcinoma in Winnipeg Advanced Pancreatic Adenocarcinoma in Quebec City Advanced Pancreatic Adenocarcinoma in Hamilton Advanced Pancreatic Adenocarcinoma in Kitchener Advanced Pancreatic Adenocarcinoma in London Advanced Pancreatic Adenocarcinoma in Halifax Advanced Pancreatic Adenocarcinoma in New York Advanced Pancreatic Adenocarcinoma in Los Angeles Advanced Pancreatic Adenocarcinoma in Chicago Advanced Pancreatic Adenocarcinoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease